D. V. Aleksantsev, Z. Mamedli, A. V. Polinovsky, U. N. Babadjanov, Kh.R. Temirsultanova, P. A. Dibirova, R. A. Setdikov, E. A. Mustafazade
{"title":"肿瘤外科手术中的位置性神经病变","authors":"D. V. Aleksantsev, Z. Mamedli, A. V. Polinovsky, U. N. Babadjanov, Kh.R. Temirsultanova, P. A. Dibirova, R. A. Setdikov, E. A. Mustafazade","doi":"10.17650/2949-5857-2024-14-2-33-37","DOIUrl":null,"url":null,"abstract":"Aim. To evaluate the frequency and clinical characteristics of positional neuropathies in patients with cancer who underwent surgery.Materials and methods. A retrospective study of medical records of patients undergoing surgical treatment in 2023, who showed signs of secondary neuropathy of the upper and/or lower extremities in the postoperative period. The main analyzed parameter was the frequency of postoperative neuropathies among patients who underwent surgery; additional parameters were the degree of neurological deficit according to the neurological deficit assessment scale, the median regression of neurological deficit. Results. The study included 29 patients who underwent surgery at the National Medical Research Center of Oncology named after N. N. Blokhin in 2023, who developed a clinical picture of positional neuropathy in the postoperative period. The overall incidence of positional neuropathies was 0.28 %. Neuropathies of the brachial plexus were predominant (96 %). A severe degree of neurological deficit was noted in 35 %, medium – in 45 %, mild – in 20 % of patients. 27.5 % of patients continued to have varying degrees of neurological deficit over a 10-month period.Conclusion. Positional neuropathies can persist for a long time; it is necessary to develop methods for their prevention.","PeriodicalId":509681,"journal":{"name":"Surgery and Oncology","volume":" 33","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Positional neuropathies in surgical oncology\",\"authors\":\"D. V. Aleksantsev, Z. Mamedli, A. V. Polinovsky, U. N. Babadjanov, Kh.R. Temirsultanova, P. A. Dibirova, R. A. Setdikov, E. A. Mustafazade\",\"doi\":\"10.17650/2949-5857-2024-14-2-33-37\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim. To evaluate the frequency and clinical characteristics of positional neuropathies in patients with cancer who underwent surgery.Materials and methods. A retrospective study of medical records of patients undergoing surgical treatment in 2023, who showed signs of secondary neuropathy of the upper and/or lower extremities in the postoperative period. The main analyzed parameter was the frequency of postoperative neuropathies among patients who underwent surgery; additional parameters were the degree of neurological deficit according to the neurological deficit assessment scale, the median regression of neurological deficit. Results. The study included 29 patients who underwent surgery at the National Medical Research Center of Oncology named after N. N. Blokhin in 2023, who developed a clinical picture of positional neuropathy in the postoperative period. The overall incidence of positional neuropathies was 0.28 %. Neuropathies of the brachial plexus were predominant (96 %). A severe degree of neurological deficit was noted in 35 %, medium – in 45 %, mild – in 20 % of patients. 27.5 % of patients continued to have varying degrees of neurological deficit over a 10-month period.Conclusion. Positional neuropathies can persist for a long time; it is necessary to develop methods for their prevention.\",\"PeriodicalId\":509681,\"journal\":{\"name\":\"Surgery and Oncology\",\"volume\":\" 33\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery and Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/2949-5857-2024-14-2-33-37\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2949-5857-2024-14-2-33-37","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的评估接受手术治疗的癌症患者发生体位性神经病的频率和临床特征。对 2023 年接受手术治疗的患者的病历进行回顾性研究,这些患者在术后出现了上肢和/或下肢继发性神经病的症状。主要分析参数为手术患者术后神经病变的频率;其他参数包括根据神经功能缺损评估量表得出的神经功能缺损程度、神经功能缺损的中位回归率。研究结果该研究包括 29 名于 2023 年在以 N. N. 命名的国家肿瘤医学研究中心接受手术的患者。Blokhin 命名的国家肿瘤医学研究中心接受手术的 29 名患者,他们在术后都出现了体位性神经病的临床表现。体位性神经病的总发病率为 0.28%。以臂丛神经病变为主(96%)。35%的患者出现严重的神经功能缺损,45%为中度缺损,20%为轻度缺损。27.5%的患者在10个月内仍有不同程度的神经功能缺损。体位性神经病可持续很长时间,因此有必要制定预防方法。
Aim. To evaluate the frequency and clinical characteristics of positional neuropathies in patients with cancer who underwent surgery.Materials and methods. A retrospective study of medical records of patients undergoing surgical treatment in 2023, who showed signs of secondary neuropathy of the upper and/or lower extremities in the postoperative period. The main analyzed parameter was the frequency of postoperative neuropathies among patients who underwent surgery; additional parameters were the degree of neurological deficit according to the neurological deficit assessment scale, the median regression of neurological deficit. Results. The study included 29 patients who underwent surgery at the National Medical Research Center of Oncology named after N. N. Blokhin in 2023, who developed a clinical picture of positional neuropathy in the postoperative period. The overall incidence of positional neuropathies was 0.28 %. Neuropathies of the brachial plexus were predominant (96 %). A severe degree of neurological deficit was noted in 35 %, medium – in 45 %, mild – in 20 % of patients. 27.5 % of patients continued to have varying degrees of neurological deficit over a 10-month period.Conclusion. Positional neuropathies can persist for a long time; it is necessary to develop methods for their prevention.